Secondary Logo

Journal Logo

February 1, 2022 - Volume 89 - Issue 2

  • Paul A. Volberding, MD
    William A. Blattner, MD
  • 1525-4135
  • 1077-9450
  • 15 issues per year
  • Infectious Diseases 34/93
    Immunology 78/158
  • 3.475
Guest Editors: Suresh Pallikkuth, PhD and Savita Pahwa, MD
Published February 1, 2022
Other Supplements

Current Issue Highlights


An Epidemic of Pediatric HIV From Reuse of Infusion Equipment in Pakistan

Syed, Muhammad Asif; Khan, Adnan; Chaudhry, Ambreen; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 89(2):121-128, February 1, 2022.



Material Hardship and Association With Sexual Risk Behavior Among Adolescent Sexual Minority Males in 3 US Cities—National HIV Behavioral Surveillance—Young Men Who Have Sex With Men, 2015

Trujillo, Lindsay; Robbins, Taylor; Morris, Elana; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 89(2):159-165, February 1, 2022.



Brief Report: No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor–Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)

Shaffer, Douglas; Kumwenda, Johnstone; Chen, Huichao; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 89(2):178-182, February 1, 2022.

HIV Disease Dynamics and Markers of Inflammation and CNS Injury During Primary HIV Infection and Their Relationship to Cognitive Performance

Longino, August A.; Paul, Robert; Wang, Yixin; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 89(2):183-190, February 1, 2022.